Pfizer wants the first FDA approval ever for an RSV vaccine for young adultsByBruce GilPublishedApril 9, 2024
$24 billion could prepare the US to tackle every viral pandemic imaginableByAnnalisa MerelliPublishedMay 11, 2023
Pfizer's RSV vaccine promise to the Global South is already several years behind scheduleByAnnalisa MerelliPublishedMay 7, 2023
How to make sense of the new CDC guidelines on covid vaccine boosters for childrenByAnnalisa MerelliPublishedApril 25, 2023
The country with the highest rate of malaria deaths in the world has approved Oxford's vaccineByFaustine NgilaPublishedApril 18, 2023
Ghana is the world's first country to approve Oxford's new malaria vaccineByFaustine NgilaPublishedApril 13, 2023
As Covid-19 shot sales dwindle, BioNTech doubles down on cancer vaccinesByAnnalisa MerelliUpdatedMarch 27, 2023
A more equitable covid vaccine rollout could have saved a life every 24 seconds in 2021ByAnnalisa MerelliPublishedMarch 10, 2023
The cholera vaccine shortage could increase the toll of the earthquake in Syria and TurkeyByAnnalisa MerelliPublishedFebruary 14, 2023
Africa's official covid vaccination rates are about to go up by a lotByAnnalisa MerelliPublishedDecember 28, 2022
Pfizer plans to sell its covid vaccine at a 10,000% markup in 2023ByAnnalisa MerelliPublishedOctober 22, 2022
Rich countries are destroying covid vaccines they hoarded while much of the world still waits for their first shotByAnnalisa MerelliPublishedOctober 20, 2022
The US's estimate for uptake of the new covid booster was off by more than 90%ByAnnalisa MerelliPublishedOctober 11, 2022
There was barely any mention of vaccine equality at the UNGAByAnnalisa MerelliPublishedSeptember 26, 2022
South Africa and India will make four vaccines without the help of rich western countriesByAnnalisa MerelliPublishedSeptember 1, 2022
240 million Americans will likely be eligible for omicron-specific vaccine boosters after Labor DayByAnnalisa MerelliPublishedAugust 24, 2022
Black men are getting 70% of monkeypox cases in North Carolina—and only 24% of the vaccinesByAnnalisa MerelliPublishedAugust 11, 2022
